ArticleJB & JS open access
Predicting Interval Pulmonary Metastasis in Extremity Soft Tissue Sarcoma Treated with Preoperative Radiotherapy: A Risk-Stratified Cohort Study of 378 Patients.
Article in JB & JS open access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Preoperative radiotherapy (RT) is widely used in high-risk extremity soft tissue sarcoma (STS) because of its benefits in local control and functional preservation. However, the interval between diagnosis and definitive surgery raises concern regarding the potential development of interval distant metastases, particularly in aggressive tumors. Data defining the incidence and predictors of such progression remain limited. Methods: We conducted a retrospective cohort study of adult patients with nonmetastatic extremity STS treated with standardized preoperative RT followed by limb-sparing surgery between 2018 and 2024. All patients underwent baseline staging and mandatory preoperative chest computed tomography. The primary end point was new distant metastasis detected before surgery. Multivariable logistic regression was used to identify independent predictors, and a clinical risk score was developed. Results: Among 378 patients, interval distant metastases occurred in 29 (7.8%), almost exclusively involving the lungs. Tumor size greater than 12 cm, synovial sarcoma histology, FNCLCC grade 3, and age 50 years or younger were independently associated with interval metastatic progression. A 4-factor risk score stratified patients into low, intermediate, and high-risk groups, with metastasis rates of 2.4%, 8.4%, and 25.6%, respectively. Discussion: Interval metastasis during preoperative RT is rare and linked to unfavorable baseline tumor biology. This supports the treatment's feasibility for most patients and highlights the need for routine preoperative chest restaging. Interval metastasis in a standardized preoperative RT protocol for extremity STS occurs mainly in patients with adverse tumor characteristics. Routine preoperative chest CT restaging is necessary, and a simple 4-factor risk score may identify patients needing enhanced surveillance and personalized counseling. Level of Evidence: Prognostic Level IV.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.